Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

The sales of the BTK inhibitor reached at least USD 11 billion worldwide in 2021

PharmaSources/CaicaiMarch 16, 2022

Tag: BTK Inhibitor , Ibrutinib , hematologic tumors

PharmaSources Customer Service